New Technologies for Outcome Measures in Retinal Disease: Review from the European Vision Institute Special Interest Focus Group

Maria Della Volpe-Waizel, Ghislaine L. Traber, Peter Maloca, Martin Zinkernagel, Ursula Schmidt-Erfurth, Gary Rubin, Botond Roska, Tilman Otto, Richard Weleber, Hendrik P.N. Scholl

Research output: Contribution to journalReview article

1 Citation (Scopus)

Abstract

Novel diagnostic tools to measure retinal function and structure are rapidly being developed and introduced into clinical use. Opportunities exist to use these informative and robust measures as endpoints for clinical trials to determine efficacy and to monitor safety of therapeutic interventions. In order to inform researchers and clinician-scientists about these new diagnostic tools, a workshop was organized by the European Vision Institute. Invited speakers highlighted the recent advances in state-of-the-art technologies for outcome measures in the field of retina. This review highlights the workshop's presentations in the context of published literature.

Original languageEnglish (US)
JournalOphthalmic Research
DOIs
StateAccepted/In press - Jan 1 2019

Fingerprint

Retinal Diseases
Public Opinion
Focus Groups
Outcome Assessment (Health Care)
Technology
Education
Retina
Research Personnel
Clinical Trials
Safety
Therapeutics

Keywords

  • Artificial intelligence
  • Diagnostics
  • Machine learning
  • Retina
  • Retinal disease
  • Technologies

ASJC Scopus subject areas

  • Ophthalmology
  • Sensory Systems
  • Cellular and Molecular Neuroscience

Cite this

Della Volpe-Waizel, M., Traber, G. L., Maloca, P., Zinkernagel, M., Schmidt-Erfurth, U., Rubin, G., ... Scholl, H. P. N. (Accepted/In press). New Technologies for Outcome Measures in Retinal Disease: Review from the European Vision Institute Special Interest Focus Group. Ophthalmic Research. https://doi.org/10.1159/000501887

New Technologies for Outcome Measures in Retinal Disease : Review from the European Vision Institute Special Interest Focus Group. / Della Volpe-Waizel, Maria; Traber, Ghislaine L.; Maloca, Peter; Zinkernagel, Martin; Schmidt-Erfurth, Ursula; Rubin, Gary; Roska, Botond; Otto, Tilman; Weleber, Richard; Scholl, Hendrik P.N.

In: Ophthalmic Research, 01.01.2019.

Research output: Contribution to journalReview article

Della Volpe-Waizel, M, Traber, GL, Maloca, P, Zinkernagel, M, Schmidt-Erfurth, U, Rubin, G, Roska, B, Otto, T, Weleber, R & Scholl, HPN 2019, 'New Technologies for Outcome Measures in Retinal Disease: Review from the European Vision Institute Special Interest Focus Group', Ophthalmic Research. https://doi.org/10.1159/000501887
Della Volpe-Waizel, Maria ; Traber, Ghislaine L. ; Maloca, Peter ; Zinkernagel, Martin ; Schmidt-Erfurth, Ursula ; Rubin, Gary ; Roska, Botond ; Otto, Tilman ; Weleber, Richard ; Scholl, Hendrik P.N. / New Technologies for Outcome Measures in Retinal Disease : Review from the European Vision Institute Special Interest Focus Group. In: Ophthalmic Research. 2019.
@article{b54409bd5a964197946ad5d485217080,
title = "New Technologies for Outcome Measures in Retinal Disease: Review from the European Vision Institute Special Interest Focus Group",
abstract = "Novel diagnostic tools to measure retinal function and structure are rapidly being developed and introduced into clinical use. Opportunities exist to use these informative and robust measures as endpoints for clinical trials to determine efficacy and to monitor safety of therapeutic interventions. In order to inform researchers and clinician-scientists about these new diagnostic tools, a workshop was organized by the European Vision Institute. Invited speakers highlighted the recent advances in state-of-the-art technologies for outcome measures in the field of retina. This review highlights the workshop's presentations in the context of published literature.",
keywords = "Artificial intelligence, Diagnostics, Machine learning, Retina, Retinal disease, Technologies",
author = "{Della Volpe-Waizel}, Maria and Traber, {Ghislaine L.} and Peter Maloca and Martin Zinkernagel and Ursula Schmidt-Erfurth and Gary Rubin and Botond Roska and Tilman Otto and Richard Weleber and Scholl, {Hendrik P.N.}",
year = "2019",
month = "1",
day = "1",
doi = "10.1159/000501887",
language = "English (US)",
journal = "Ophthalmic Research",
issn = "0030-3747",
publisher = "S. Karger AG",

}

TY - JOUR

T1 - New Technologies for Outcome Measures in Retinal Disease

T2 - Review from the European Vision Institute Special Interest Focus Group

AU - Della Volpe-Waizel, Maria

AU - Traber, Ghislaine L.

AU - Maloca, Peter

AU - Zinkernagel, Martin

AU - Schmidt-Erfurth, Ursula

AU - Rubin, Gary

AU - Roska, Botond

AU - Otto, Tilman

AU - Weleber, Richard

AU - Scholl, Hendrik P.N.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Novel diagnostic tools to measure retinal function and structure are rapidly being developed and introduced into clinical use. Opportunities exist to use these informative and robust measures as endpoints for clinical trials to determine efficacy and to monitor safety of therapeutic interventions. In order to inform researchers and clinician-scientists about these new diagnostic tools, a workshop was organized by the European Vision Institute. Invited speakers highlighted the recent advances in state-of-the-art technologies for outcome measures in the field of retina. This review highlights the workshop's presentations in the context of published literature.

AB - Novel diagnostic tools to measure retinal function and structure are rapidly being developed and introduced into clinical use. Opportunities exist to use these informative and robust measures as endpoints for clinical trials to determine efficacy and to monitor safety of therapeutic interventions. In order to inform researchers and clinician-scientists about these new diagnostic tools, a workshop was organized by the European Vision Institute. Invited speakers highlighted the recent advances in state-of-the-art technologies for outcome measures in the field of retina. This review highlights the workshop's presentations in the context of published literature.

KW - Artificial intelligence

KW - Diagnostics

KW - Machine learning

KW - Retina

KW - Retinal disease

KW - Technologies

UR - http://www.scopus.com/inward/record.url?scp=85070499078&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85070499078&partnerID=8YFLogxK

U2 - 10.1159/000501887

DO - 10.1159/000501887

M3 - Review article

AN - SCOPUS:85070499078

JO - Ophthalmic Research

JF - Ophthalmic Research

SN - 0030-3747

ER -